Biol Reprod
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print December 15, 2004.
Biol Reprod 2004, 10.1095/biolreprod.104.033225
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An addition or correction has been published
Right arrow All Versions of this Article:
72/4/944    most recent
biolreprod.104.033225v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Enright, B.P.
Right arrow Articles by Tian, X.C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Enright, B.P.
Right arrow Articles by Tian, X.C.
Agricola
Right arrow Articles by Enright, B.P.
Right arrow Articles by Tian, X.C.
BIOLOGY OF REPRODUCTION 72, 944–948 (2005)
DOI: 10.1095/biolreprod.104.033225
© 2005 by the Society for the Study of Reproduction, Inc.

Methylation and Acetylation Characteristics of Cloned Bovine Embryos from Donor Cells Treated with 5-aza-2'-Deoxycytidine1

B.P. Enright3,4, L.-Y. Sung4, C.-C. Chang4, X. Yang4, and X.C. Tian2,3,4

Department of Animal Science/Center for Regenerative Biology,4 University of Connecticut, Storrs, Connecticut 06269

Differentiated somatic cells and embryos cloned from somatic cells by nuclear transfer (NT) have higher levels of DNA methylation than gametes and early embryos produced in vivo. Reducing DNA methylation in donor cells before NT by treating them with chemicals such as the DNA methyl-transferase inhibitor (5-aza-2'-deoxycytidine; 5-aza-dC) may improve cloning efficiency of NT embryos by providing donor cells with similar epigenetic characteristics as in vivo embryos. Previously, high levels of this reagent were used to treat donor cells, and decreased development of cloned embryos was observed. In this study, we tested a lower range (0.005 to 0.08 µM) of this drug and used cell cycle distribution changes as an indicator of changes in the characteristics of donor cells. We found that at 0.01 µM 5-aza-dC induced changes in the cycle stage distribution of donor cells, increased the fusion rate of NT embryos, and had no deleterious effect on the percentage of blastocyst development. Levels of 5-aza-dC greater than 0.01 µM significantly decreased embryo development. Embryos cloned from donor cells treated with a low dose of 5-aza-dC had higher levels of DNA methylation than embryos produced by in vitro fertilization, but they also had higher levels of histone acetylation. Although 5-aza-dC at 0.04 µM or higher reduced DNA methylation and histone acetylation levels to those of in vitro-fertilized embryos, development to blastocyst was reduced, suggesting that this concentration of the drug was detrimental. In summary, 5-aza-dC at 0.01 µM altered donor cell characteristics while showing no deleterious effects on embryos cloned from treated cells.

1 This manuscript is a scientific contribution of the Storrs Agricultural Experimental Station at the University of Connecticut and was supported by grants to X.Y. and X.C.T.

2 Correspondence: X.C. Tian, Agricultural Biotechnology Laboratory, 1392 Storrs Road, Storrs, CT 06269-4243. FAX: 860 486 8809; xtian{at}canr.uconn.edu

3 Current address: National Institutes of Health/National Cancer Institute, Bethesda, MD 20892




This article has been cited by other articles:


Home page
ReproductionHome page
B.-G. Jeon, G. Coppola, S. D Perrault, G.-J. Rho, D. H Betts, and W A. King
S-adenosylhomocysteine treatment of adult female fibroblasts alters X-chromosome inactivation and improves in vitro embryo development after somatic cell nuclear transfer
Reproduction, June 1, 2008; 135(6): 815 - 828.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
H. Niemann, X C. Tian, W A. King, and R. S F Lee
Epigenetic reprogramming in embryonic and foetal development upon somatic cell nuclear transfer cloning
Reproduction, February 1, 2008; 135(2): 151 - 163.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
L.-Y. Sung, P.-C. Shen, B.-S. Jeong, J. Xu, C.-C. Chang, W. T.K. Cheng, J.-S. Wu, S.-N. Lee, D. Broek, D. Faber, et al.
Premature Chromosome Condensation Is Not Essential for Nuclear Reprogramming in Bovine Somatic Cell Nuclear Transfer
Biol Reprod, February 1, 2007; 76(2): 232 - 240.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. Yang, S. Yang, N. Beaujean, Y. Niu, X. He, Y. Xie, X. Tang, L. Wang, Q. Zhou, and W. Ji
Epigenetic Marks in Cloned Rhesus Monkey Embryos: Comparison with Counterparts Produced In Vitro
Biol Reprod, January 1, 2007; 76(1): 36 - 42.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
R. Blelloch, Z. Wang, A. Meissner, S. Pollard, A. Smith, and R. Jaenisch
Reprogramming Efficiency Following Somatic Cell Nuclear Transfer Is Influenced by the Differentiation and Methylation State of the Donor Nucleus
Stem Cells, September 1, 2006; 24(9): 2007 - 2013.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society for the Study of Reproduction.